Tags: Drug.

Lorcainide (Lorcainide hydrochloride) is a Class 1c antiarrhythmic agent that is used to help restore normal heart rhythm and conduction in patients with premature ventricular contractions ventricular tachycardiac [7] and Wolff-Parkinson-White syndrome. [9] Lorcainide was developed by Janssen Pharmaceutica (Belgium) in 1968 under the commercial name Remivox and is designated by code numbers R-15889 or Ro 13-1042/001.

Lorcainide.svg
ATC prefix
C01
ATC suffix
BC07
CAS number
59729-31-6
FDA UNII code
KGJ2T0N7IQ
IUPAC name
N-(4-chlorophenyl)-N-(1-isopropylpiperidin-4-yl)-2-phenylacetamide
PubChem
42884

Loading...

This page contains content from the copyrighted Wikipedia article "Lorcainide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.